Four datasets acquired from the GEO platform, namely GSE26566, GSE32225, GSE32958 and GSE76311, were used to identify the low-expressing samples of SPRYD4 in CCA compared to normal bile duct tissues (Fig. 1B). This evidence concerns the gene SPRYD4 and cholangiocarcinoma.